The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Acta Pharmacologica Sinica

• Publication date

  2017-11-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/aps.2017.157PMID 29188802PMCID PMC5843836
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis

  2016cited by this paper
• The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling.

  2014cited by this paper
• The oncoprotein HBXIP up-regulates SCG3 through modulating E2F1 and miR-509-3p in hepatoma cells.

  2014cited by this paper
• Actin dynamics, architecture, and mechanics in cell motility.

  2014cited by this paper
• ERK/CANP rapid signaling mediates 17β-estradiol-induced proliferation of human breast cancer cell line MCF-7 cells.

  2014cited by this paper
• (R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motility.

  2014cited by this paper
• Capn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metalloproteinase 2 expression

  2014cited by this paper
• FiloDetect: automatic detection of filopodia from fluorescence microscopy images

  2013cited by this paper
• The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas

  2013cited by this paper
• The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells

  2013cited by this paper
• The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells

  2013cited by this paper
• The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells.

  2013cited by this paper
• The l-α-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity

  2012cited by this paper
• The Oncoprotein HBXIP Uses Two Pathways to Up-regulate S100A4 in Promotion of Growth and Migration of Breast Cancer Cells*

  2012cited by this paper
• Hepatitis B Virus X Protein Drives Multiple Cross-Talk Cascade Loops Involving NF-κB, 5-LOX, OPN and Capn4 to Promote Cell Migration

  2012cited by this paper
• The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK

  2011cited by this paper
• Life at the leading edge.

  2011cited by this paper
• Hepatitis B virus X protein promotes hepatoma cell proliferation via upregulation of MEKK2

  2011cited by this paper
• L-α-lysophosphatidylinositol meets GPR55: a deadly relationship.

  2011cited by this paper
• A comprehensive method for lipid profiling by liquid chromatography-ion cyclotron resonance mass spectrometry[S]

  2011cited by this paper
• The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation

  2011cited by this paper
• miR-520b Regulates Migration of Breast Cancer Cells by Targeting Hepatitis B X-interacting Protein and Interleukin-8*

  2011cited by this paper
• Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.

  2011cited by this paper
• Downregulation of Dickkopf-1 is responsible for high proliferation of breast cancer cells via losing control of Wnt/β-catenin signaling

  2010cited by this paper
• Contribution of Filopodia to Cell Migration: A Mechanical Link between Protrusion and Contraction

  2010cited by this paper
• Hepatitis B virus X protein upregulates expression of calpain small subunit 1 via nuclear facter‐κB/p65 in hepatoma cells

  2010cited by this paper
• Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.

  2010cited by this paper
• THEMED ISSUE: CANNABINOIDS RESEARCH PAPER A role for L-a-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells

  2010cited by this paper
• A positive feedback between activated extracellularly regulated kinase and cyclooxygenase/lipoxygenase maintains proliferation and migration of breast cancer cells.

  2009cited by this paper
• The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

  2009cited by this paper
• Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2.

  2008cited by this paper
• Interaction of Hepatitis B Viral Oncoprotein with Cellular Target HBXIP Dysregulates Centrosome Dynamics and Mitotic Spindle Formation*

  2008cited by this paper
• The calpain small subunit regulates cell-substrate mechanical interactions during fibroblast migration

  2008cited by this paper
• GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

  2008cited by this paper
• Identification of GPR55 as a lysophosphatidylinositol receptor.

  2007cited by this paper
• G-protein-coupled receptors and cancer

  2007cited by this paper
• Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells.

  2005cited by this paper
• Overexpression of RhoA, Rac1, and Cdc42 GTPases Is Associated with Progression in Testicular Cancer

  2004cited by this paper
• HBXIP functions as a cofactor of survivin in apoptosis suppression

  2003cited by this paper
• Caspase activation during phorbol ester-induced apoptosis requires ROCK-dependent myosin-mediated contraction

  2003cited by this paper
• Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.

  2001cited by this paper
• Evaluation of Plasma Lysophospholipids for Diagnostic Significance Using Electrospray Ionization Mass Spectrometry (ESI‐MS) Analyses

  2000cited by this paper
• Signalling pathways involved in the mitogenic action of lysophosphatidylinositol.

  1995cited by this paper

• GPR55 in the tumor microenvironment of pancreatic cancer controls tumorigenesis

  2025cites this paper
• G protein-coupled receptors (GPCRs) in cancer prognosis and therapeutics: A comprehensive review.

  2025cites this paper
• Newcastle disease virus promotes spreading infection through vimentin-dependent tight junction injury mediated by MLC/p-MLC activation

  2025cites this paper
• GPR55: Physiological functions and therapeutic potential in depression.

  2025cites this paper
• GPR55 senses lactate to sustain motility in prostate cancer cells

  2025cites this paper
• Nanoinducer-mediated mitochondria-selective degradation enhances T cell immunotherapy against multiple cancers

  2025cites this paper
• The Use of Biologics for Targeting GPCRs in Metastatic Cancers

  2025cites this paper
• The role of the key endocannabinoids and their receptros in breast cancer

  2024cites this paper
• Mechanistic insights into the impact of WIN 55, 212-2, a synthetic cannabinoid, on adhesion molecules PECAM-1 and VE-cadherin in HeLa cells: implications on cancer processes

  2024cites this paper
• The Interaction of the Endocannabinoid Anandamide and Paracannabinoid Lysophosphatidylinositol during Cell Death Induction in Human Breast Cancer Cells

  2024influential citation
• Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors

  2023cites this paper
• Involvement of cannabinoid receptors and adenosine A2B receptor in enhanced migration of lung cancer A549 cells induced by γ-ray irradiation.

  2023cites this paper
• Multicomponent Lipid Nanoparticles for RNA Transfection

  2023cites this paper
• The Mechanisms of GPR55 Receptor Functional Selectivity during Apoptosis and Proliferation Regulation in Cancer Cells

  2023cites this paper
• Plasma lipids signify the progression of precancerous gastric lesions to gastric cancer: a prospective targeted lipidomics study

  2022cites this paper
• Mast Cell–Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth

  2022cites this paper
• HBXIP is a novel regulator of the unfolded protein response that sustains tamoxifen resistance in ER+ breast cancer

  2022cites this paper
• The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling.

  2022cites this paper
• Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1H)-One Scaffold

  2022cites this paper
• The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell’s metabolic crosstalk

  2022cites this paper
• Use of Cannabis and Cannabinoids for Treatment of Cancer

  2022cites this paper
• Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis

  2021cites this paper
• Overview of Medicinal Cannabis

  2021cites this paper
• Expression of Lysophosphatidylinositol Signaling-relevant Molecules in Colorectal Cancer

  2021cites this paper
• The oncogenic role of HBXIP.

  2021cites this paper
• Hepatitis B X‐interacting protein, involved in increasing proliferation and cell migration, is a prognostic marker in head and neck squamous cell carcinoma

  2021cites this paper
• Screening of tumor-targeting peptides for diagnosis and therapy through phage display technology

  2021cites this paper
• Gene Expression Data Mining Reveals the Involvement of GPR55 and Its Endogenous Ligands in Immune Response, Cancer, and Differentiation

  2021cites this paper
• Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches

  2021cites this paper
• A Guide to Targeting the Endocannabinoid System in Drug Design

  2020cites this paper
• The GPR55 antagonist CID16020046 mitigates advanced glycation end products (AGEs)- induced chondrocyte activation.

  2020cites this paper
• Overexpression of lncRNA H19 leads to reduced proliferation in TSCC cells through miR-675-5p/GPR55

  2020cites this paper
• Lipidomics investigations into the tissue phospholipidomic landscape of invasive ductal carcinoma of the breast

  2020cites this paper
• Discovery of 1,4-Naphthoquinones as a New Class of Antiproliferative Agents Targeting GPR55.

  2019cites this paper
• The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis

  2019cites this paper
• Development of Chromen-4-one Derivatives as (Ant)agonists for the Lipid-Activated G Protein-Coupled Receptor GPR55 with Tunable Efficacy

  2019cites this paper
• Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer

  2019cites this paper
• Structure-Activity Relationship of the GPR55 Antagonist, CID16020046

  2018cites this paper
• The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways

  2018cites this paper
• The role of GPR55 protein in proliferation, migration and invasion in human pancreatic neuroendocrine tumor cells

  year unknowncites this paper